Sanara MedTech Inc.
SMTI
$31.64
-$0.08-0.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -124.59% | -2.33% | 23.50% | 18.32% | 45.79% |
| Total Depreciation and Amortization | 20.17% | 29.90% | 33.99% | 35.78% | 55.00% |
| Total Amortization of Deferred Charges | 3,928.85% | 7,200.00% | -- | -- | -- |
| Total Other Non-Cash Items | 802.48% | 0.28% | -2.27% | 206.61% | 229.76% |
| Change in Net Operating Assets | 72.20% | 11.53% | -6.62% | -354.11% | -733.42% |
| Cash from Operations | 99.27% | 40.69% | 51.46% | 40.22% | 41.57% |
| Capital Expenditure | 22.36% | 28.87% | -226.97% | -133.13% | -80.29% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -100.00% | -53.33% |
| Cash Acquisitions | -- | 100.00% | -295.17% | -295.17% | -295.17% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 35.23% | 37.93% | -781.62% | -215.81% | -190.67% |
| Total Debt Issued | 202.83% | 202.83% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -62.49% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -131.89% | 9.51% | -2.75% | 18.55% | -52.80% |
| Cash from Financing | 80.13% | 93.03% | 4,320.37% | 2,173.38% | 1,636.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 381.52% | 347.96% | 101.36% | 49.66% | 60.68% |